ImmunoPrecise Antibodies (STU:TQB) Short-Term Debt : €0.00 Mil (As of Jan. 2025)

View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies Short-Term Debt?

ImmunoPrecise Antibodies's Short-Term Debt for the quarter that ended in Jan. 2025 was €0.00 Mil.

ImmunoPrecise Antibodies's quarterly Short-Term Debt increased from Jul. 2024 (€1.75 Mil) to Oct. 2024 (€2.06 Mil) but then declined from Oct. 2024 (€2.06 Mil) to Jan. 2025 (€0.00 Mil).

ImmunoPrecise Antibodies's annual Short-Term Debt declined from Apr. 2022 (€0.96 Mil) to Apr. 2023 (€0.00 Mil) but then stayed the same from Apr. 2023 (€0.00 Mil) to Apr. 2024 (€0.00 Mil).

ImmunoPrecise Antibodies Short-Term Debt Historical Data

The historical data trend for ImmunoPrecise Antibodies's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Short-Term Debt Chart

ImmunoPrecise Antibodies Annual Data

Trend

Dec14

Dec15

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Short-Term Debt

Get a 7-Day Free Trial

1.39

0.96

ImmunoPrecise Antibodies Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Short-Term Debt	Get a 7-Day Free Trial															-	-	1.75	2.06	-

ImmunoPrecise Antibodies Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

ImmunoPrecise Antibodies Short-Term Debt Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

IPA:USA

Address

Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701

Website

https://www.ipatherapeutics.com

ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

ImmunoPrecise Antibodies Headlines

No Headlines